 - Any Grade 3 laboratory abnormality as defined by the National Cancer Institute Common Terminology Criteria for Adverse Events NCI CTCAE Toxicity Grading Scale, except subjects with Grade 3 dyslipidemia with triglyceride or cholesterol elevations unless clinical assessment foresees an immediate health risk to the subject 